ASHP Midyear 2025 Clinical Meeting & Exhibition: Location, Dates, What to Expect, and What’s Happeninghttps://shieldshealthsolutions.com/content/themes/blade/images/empty/thumbnail.jpg150150Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Every year, more than 20,000 professionals gather for the ASHP Midyear Clinical Meeting & Exhibition. Now in its 60th year, the Midyear Clinical Meeting remains the can’t-miss event where pharmacy’s…
Optimizing Oncology Outcomes: The Impact of Pharmacist-Led Clinical Interventionshttps://shieldshealthsolutions.com/content/uploads/2024/11/white-papers.svg7070Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Cancer care is complex. For patients prescribed oral oncolytics, managing side effects, staying on schedule, and coordinating care can be overwhelming. These challenges often lead to missed doses, therapy interruptions,…
Shields PGY1 Community-Based Residency Programhttps://shieldshealthsolutions.com/content/uploads/2024/11/blog.svg7070Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Launch Your Specialty Pharmacy Career with Expert Mentorship and Real-World Experience Are you a pharmacy student or recent graduate looking to elevate your career? The Shields PGY1 Community-Based Residency Program…
The Role of Health System Specialty Pharmacy in Cardiometabolic Disease Carehttps://shieldshealthsolutions.com/content/uploads/2024/11/white-papers.svg7070Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Unlock Better Outcomes in Cardiometabolic Disease Care Cardiometabolic disease (CMD) is one of the most pressing healthcare challenges of our time—driving trillions in costs and impacting millions of lives. From diabetes…
NASP 2025 Annual Meeting & Expo: Location, Dates, What to Expect, and What’s Happeninghttps://shieldshealthsolutions.com/content/themes/blade/images/empty/thumbnail.jpg150150Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Each year, NASP members, industry thought leaders, and healthcare veterans from around the country come together to shape the future of specialty pharmacy and the patient journey. Join us to…
Artificial Intelligence in Specialty Pharmacy: Innovation That Empowers, Not Replaceshttps://shieldshealthsolutions.com/content/uploads/2024/11/blog.svg7070Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Will AI replace pharmacists and technicians? It’s a question that has sparked both curiosity and concern across the healthcare landscape, and understandably so, as artificial intelligence (AI) has already had…
Unlocking the Full Potential of Your DIY Specialty Pharmacy Program: Why Strategic Partnership Mattershttps://shieldshealthsolutions.com/content/uploads/2024/11/blog.svg7070Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Specialty pharmacy is one of the fastest-growing and most essential parts of today’s healthcare landscape — and you’re likely already feeling both the opportunity and the pressure. As the number…
How CHRISTUS Health Reimagined Diabetes Support Through Health System Specialty Pharmacyhttps://shieldshealthsolutions.com/content/uploads/2024/11/case-studies.svg7070Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacyhttps://shieldshealthsolutions.com/content/uploads/2024/11/white-papers.svg7070Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
According to the CDC, approximately 38 million Americans have diabetes (about 1 in 10) and approximately 90-95% of those have type 2 diabetes. GLP-1 and GLP-1/GIP agonists are now recognized…
Addressing GLP-1 Access and Adherence Challenges with Specialty Pharmacy Solutionshttps://shieldshealthsolutions.com/content/uploads/2024/11/blog.svg7070Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Whether through social media, traditional news outlets, or word of mouth, discussions about GLP-1 therapy are everywhere. These medications, originally approved by the FDA for the treatment of Type 2…